Johnson & Johnson shareholders at the 2026 Annual Meeting elected all 12 director nominees, approved executive compensation and auditor ratification, but rejected the independent board chair proposal.
Key takeaways
All 12 director nominees elected to the Board with overwhelming support, averaging over 1.7 billion shares for each.
Advisory vote approved named executive officer compensation with 1.64 billion shares for versus 92 million against.
PricewaterhouseCoopers LLP ratified as independent auditor for 2026 with 1.91 billion shares for and zero broker non-votes.
Shareholder proposal for independent board chair failed, with 1.33 billion against versus 406 million for.
Meeting held on April 23, 2026, with significant broker non-votes of 314 million shares on most proposals.